NYSE USD

Avanos Medical, Inc. (AVNS)

12.65
+0.07
+(0.56%)
At close: May 9 at 4:00:02 PM EDT
12.65
0.00
(0.00%)
After hours: May 9 at 6:22:52 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
689,200
687,800
673,300
684,100
587,000
Cost of Revenue
312,900
306,500
293,600
289,900
287,800
Gross Profit
376,300
381,300
379,700
394,200
299,200
Operating Expense
329,500
340,800
375,500
358,700
338,200
Operating Income
46,800
40,500
4,200
35,500
-39,000
Net Non Operating Interest Income Expense
-5,200
-7,100
-12,100
-8,800
-3,100
Other Income Expense
--
-436,700
--
--
--
Pretax Income
-395,100
-403,300
-7,900
26,700
-42,100
Tax Provision
-14,900
-17,000
2,000
5,200
-11,200
Net Income Common Stockholders
-384,600
-392,100
-61,800
50,500
6,300
Diluted NI Available to Com Stockholders
-384,600
-392,100
-61,800
50,500
6,300
Basic EPS
-8.37
-8.53
-1.32
1.08
0.11
Diluted EPS
-8.37
-8.53
-1.32
1.07
0.11
Basic Average Shares
45,975
46,000
46,600
46,900
48,100
Diluted Average Shares
46,025
46,000
46,600
47,300
48,600
Total Operating Income as Reported
-389,900
-396,200
4,200
35,500
-39,000
Total Expenses
642,400
647,300
669,100
648,600
626,000
Net Income from Continuing & Discontinued Operation
-384,600
-392,100
-61,800
50,500
6,300
Normalized Income
40,031.18
32,058.60
-9,900
21,500
-30,900
Interest Income
6,000
5,100
2,900
1,200
200
Interest Expense
11,200
12,200
15,000
10,000
3,300
Net Interest Income
-5,200
-7,100
-12,100
-8,800
-3,100
EBIT
-383,900
-391,100
7,100
36,700
-38,800
EBITDA
-340,200
-345,600
53,200
84,400
-500
Reconciled Cost of Revenue
312,900
306,500
293,600
289,900
287,800
Reconciled Depreciation
43,700
45,500
46,100
47,700
38,300
Net Income from Continuing Operation Net Minority Interest
-380,200
-386,300
-9,900
21,500
-30,900
Total Unusual Items Excluding Goodwill
-436,700
-436,700
0
0
--
Total Unusual Items
-436,700
-436,700
0
0
--
Normalized EBITDA
96,500
91,100
53,200
84,400
-500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-16,468.82
-18,341.40
0
0
0
12/31/2021 - 10/21/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNMD CONMED Corporation
57.08
-1.16%
 
ZIMV ZimVie Inc.
8.76
-4.68%
 
BVS Bioventus Inc.
6.68
-1.76%
 
OFIX Orthofix Medical Inc.
12.11
-1.62%
 
IART Integra LifeSciences Holdings Corporation
12.25
-4.97%
 
VREX Varex Imaging Corporation
6.88
-20.46%
 
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
 
HAE Haemonetics Corporation
68.19
+0.26%
 
SRDX Surmodics, Inc.
26.76
-1.65%
 
INGN Inogen, Inc.
6.24
-1.73%